Results for
"[search-keyword]"
Sponsor content
264 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AFT PHARMACEUTICALS PARACETAMOL & CAFFEINE TAB film coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AFT PHARMACEUTICALS PARACETAMOL & CAFFEINE SOFT GEL CAPS soft capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LORAZEPAM-AFT lorazepam 4 mg/1 mL solution for injection ampoule.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MEROPENEM-AFT meropenem (as trihydrate) 1000 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MEROPENEM-AFT meropenem (as trihydrate) 500 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AFT PHARMACEUTICALS PARACETAMOL SOFT GEL CAPS paracetamol 500 mg soft capsule blister pack.
-
Prescription medicine registrationActive ingredients: meropenem trihydrate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Plerixafor-AFT plerixafor 24 mg/1.2 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DAPTOMYCIN-AFT daptomycin 500 mg powder for injection vial.
This webpage on the TGA website was printed on 10 Sep 2024. Printed content may be out of date. For up-to-date information, always refer to the digital version: https://www.tga.gov.au/resources/sponsor/aft-pharmaceuticals-pty-ltd